Home
About
Contact
Issue Archive
Special Issues
Supplements

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

PMO Print Edition

PMO Weekly e‑Newsletter

I have reviewed and consent to the terms of PMO's Privacy Policy, and PMO has my permission to retain my information in its database, and to forward pertinent communications to me.

PMO Interview with the Innovator Series
Conference Correspondent
Web Exclusives
Videos

PMO Interview with the Innovator Series
Conference Correspondent
Web Exclusives
Videos

Home
About
Contact
Issue Archive
Special Issues
Supplements

From Molecular Case Studies: Genomics of exceptional responder to NOTCH inhibitor

Normal T-cell development requires Notch signaling but hyperactivity can lead to cancer. Source link

In the News

May 19, 2016

Two-pronged attack on chemotherapy-resistant leukemia cells

May 18, 2016

An Early Look at Research From the 2016 ASCO Annual Meeting

May 18, 2016

Drug against breast cancer is also highly potent against a frequent form of leukaemia

May 17, 2016

Improving natural killer cancer therapy: Study

Keep up to date with all of our news! Sign me up!

Copyright 2023. Amplity Medical Communications. All Rights Reserved. Privacy Policy. Sitemap.

By continuing to browse this site, you agree to our use of cookies.